1368.80
1.97%
KRChoksey
EBITDA beat our estimate due to improved products and geographical mix.
The stock is trading at 24.9x/19.4x based on FY25E/FY26E EPS respectively.
Glenmark Pharmaceuticals Ltd. has lost -21.26% in the last 6 Months
More from Glenmark Pharmaceuticals Ltd.
Recommended